Integra Lifesciences Holdings Corp financial data

Symbol
IART on Nasdaq
Location
1100 Campus Road, Princeton, NJ
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Jul 31, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 120 % -66.3%
Quick Ratio 48.2 % -60.5%
Debt-to-equity 181 % +21.7%
Return On Equity -35.6 % -2469%
Return On Assets -12.7 % -2197%
Operating Margin -30.9 % -861%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 77.9M shares +0.42%
Entity Public Float 2.19B USD -32.8%
Common Stock, Value, Issued 923K USD +0.76%
Weighted Average Number of Shares Outstanding, Basic 76.7M shares -0.92%
Weighted Average Number of Shares Outstanding, Diluted 76.7M shares -0.92%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 1.62B USD +3.53%
Costs and Expenses 2.12B USD +41.2%
Operating Income (Loss) -501M USD -888%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -559M USD -2166%
Income Tax Expense (Benefit) -58.2M USD -1809%
Net Income (Loss) Attributable to Parent -501M USD -2217%
Earnings Per Share, Basic -6 USD/shares -2277%
Earnings Per Share, Diluted -6 USD/shares -2277%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 218M USD +1.24%
Accounts Receivable, after Allowance for Credit Loss, Current 285M USD +4.92%
Inventory, Net 465M USD +10.3%
Other Assets, Current 36.1M USD +25.5%
Assets, Current 1.14B USD +2.75%
Deferred Income Tax Assets, Net 103M USD +125%
Property, Plant and Equipment, Net 435M USD +16.4%
Operating Lease, Right-of-Use Asset 137M USD -7.39%
Intangible Assets, Net (Excluding Goodwill) 1.19B USD -2.61%
Goodwill 616M USD -44.2%
Other Assets, Noncurrent 46.2M USD -34.7%
Assets 3.67B USD -9.98%
Employee-related Liabilities, Current 66.9M USD -3.84%
Accrued Liabilities, Current 131M USD +28.2%
Contract with Customer, Liability, Current 11.1M USD +12.1%
Liabilities, Current 930M USD +183%
Contract with Customer, Liability, Noncurrent 11M USD +31%
Deferred Income Tax Liabilities, Net 60.1M USD -30.6%
Operating Lease, Liability, Noncurrent 159M USD -6.07%
Other Liabilities, Noncurrent 253M USD +63.5%
Liabilities 2.63B USD +3.5%
Accumulated Other Comprehensive Income (Loss), Net of Tax -30.9M USD -65%
Retained Earnings (Accumulated Deficit) 431M USD -53.8%
Stockholders' Equity Attributable to Parent 1.04B USD -32.3%
Liabilities and Equity 3.67B USD -9.98%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -11.3M USD -171%
Net Cash Provided by (Used in) Financing Activities 35.4M USD -90.1%
Net Cash Provided by (Used in) Investing Activities -35.9M USD +33.4%
Common Stock, Shares Authorized 240M shares 0%
Common Stock, Shares, Issued 92.3M shares +0.81%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -7.27M USD -102%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 218M USD +1.24%
Deferred Tax Assets, Valuation Allowance 15.5M USD +24.2%
Deferred Tax Assets, Gross 240M USD +0.23%
Operating Lease, Liability 173M USD -5.82%
Payments to Acquire Property, Plant, and Equipment 28.9M USD +87%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -513M USD -557500%
Lessee, Operating Lease, Liability, to be Paid 255M USD -6.5%
Property, Plant and Equipment, Gross 803M USD +13.4%
Operating Lease, Liability, Current 14.2M USD -2.99%
Lessee, Operating Lease, Liability, to be Paid, Year Two 20.1M USD -2.86%
Lessee, Operating Lease, Liability, to be Paid, Year One 20.3M USD -10.8%
Deferred Income Tax Expense (Benefit) -1.83M USD +35.9%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 81.9M USD -7.9%
Lessee, Operating Lease, Liability, to be Paid, Year Three 17.8M USD -8.16%
Deferred Tax Assets, Operating Loss Carryforwards 27.4M USD -4.96%
Preferred Stock, Shares Authorized 15M shares 0%
Unrecognized Tax Benefits 826K USD +1.72%
Lessee, Operating Lease, Liability, to be Paid, Year Four 17.4M USD +0.83%
Operating Lease, Payments 5.89M USD +2.72%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 14.9M USD -25.5%
Deferred Tax Assets, Net of Valuation Allowance 225M USD -1.09%
Interest Expense 52.9M USD +5.72%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares